Posts tagged as:

OTC drugs

This year’s Health Datapalooza will be held on June 5-6, at the Washington Convention Center in Washington, DC. The event will feature exciting new products, services, applications, and features based on open source health data. Entrepreneurs across the country are submitting their innovations to be judged by panels comprised of health care professionals, community leaders, and consumers. The best inventions will be showcased during the event. It’s an exciting opportunity for entrepreneurs and a great way for pharmacists to stay on top of the next big thing in the healthcare data industry. [click to continue…]

{ 1 comment }

OTC Morning After Pill mired in ongoing controversy

by pharmacy on January 24, 2012

Amid a storm of controversy swirling around hot button political issues like abortion, personhood, birth control, and sex education in schools, RU486 – a contraceptive sold as Plan B One-Step, Ella, and Next Choice – was an understandable target. [click to continue…]

{ 0 comments }

According to Dutch researchers, very few women actually benefit from taking low-dose aspirin to help prevent strokes. Most doctors agree that aspirin is beneficial for patients with a history of heart issues, but there has always been controversy over aspirin’s efficacy as a preventative measure, and the findings of the Dutch study bear out these concerns. [click to continue…]

{ 0 comments }

The debate about morning after contraception is unlikely to be resolved soon. Court cases are still pending for pharmacists who object to selling the morning after pill because they believe it to conflict with their religious and/or ethical beliefs. In the mean time, a new morning after pill has been made available in Europe that is said to have a better track record for preventing pregnancy after unprotected sex.

So far only available in Europe and by prescription, the new drug, ellaOne, appears to be longer lasting and more effective than the currently available Plan B birth control. In a recent study of 1700 women half were given Plan B and the other half ellaOne after having unprotected sex. The study found that the instance of pregnancy in the Plan B group was 2.6 percent while the rate in the ellaOne group was 1.8 percent. [click to continue…]

{ 0 comments }

Pharmacy Chains Receiving Plentiful H1N1

by Toby Roberts on December 18, 2009

Reports this week show that doses of the H1N1 are in high supply as pharmacy chains across the country have received increased stock.  Although recent reports are that the flu strain is decreasing, officials are still urging everyone to get the vaccine and suggesting that pharmacists continue to discuss it with patients to avoid future large outbreaks.

States that have had restrictions on the vaccine are now lifting them to make it available to everyone. Some had been prioritizing health care workers, pregnant women, infants, and others with high risk of complications. Now those prioritizations are being lifted and all of the general population is being encouraged to get vaccinated.

The Department of Health and Human Services reports that traditionally interest in the seasonal flu vaccine drops around the holidays even though the flu itself tends to surge in January and February.  Officials hope that a surge in H1N1 can be prevented by a renewed push to vaccinate everyone during the holiday season.

http://www.msnbc.msn.com/id/34465289/

{ 0 comments }

FDA Targets Medication Usage Errors

by Toby Roberts on November 6, 2009

This week the FDA launched a program aimed at reducing the number of injuries caused by preventable medication errors. The FDA is currently working with the Centers for Disease Control and Prevention to come up with accurate estimates of the number of deaths due to medication misuse.

A large area of concern is the possible interactions of over the counter medications.  On the heels of the reexamination of the appropriate 24-hour dosages of acetometaphine, the FDA wants to focus on informing consumers of appropriate dosages and making those dosages easier to determine. New guidelines have recently been issued for medications that come with measuring devices such as cups or droppers.

The Safe Use Initiative is aimed at cutting in half the estimated 100,000 hospitalizations that occur each year from accidental and intentional misuse of medication. The hope is that by combining consumer education efforts with examination and revision of package and instructional standards the potential for misuse will drop dramatically.

http://www.cnn.com/2009/HEALTH/11/04/medication.misuse.fda/

{ 0 comments }

© RPh on the Go, All Rights Reserved.